{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:12:49Z","timestamp":1782839569829,"version":"3.54.5"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.1093\/aje\/kwu159","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T07:08:48Z","timestamp":1406876928000},"page":"545-555","source":"Crossref","is-referenced-by-count":107,"title":["An Updated Natural History Model of Cervical Cancer: Derivation of Model Parameters"],"prefix":"10.1093","volume":"180","author":[{"given":"Nicole G.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20170522094145_KWU159C1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1055-9965.EPI-10-1130","article-title":"The need for forward-looking decision analyses to guide cervical cancer prevention","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"key\n\t\t\t\t20170522094145_KWU159C2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","year":"1999","journal-title":"J Pathol"},{"issue":"11","key":"key\n\t\t\t\t20170522094145_KWU159C3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","year":"2007","journal-title":"J Infect Dis"},{"issue":"9590","key":"key\n\t\t\t\t20170522094145_KWU159C4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"key\n\t\t\t\t20170522094145_KWU159C5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","year":"2007","journal-title":"Int J Cancer"},{"issue":"suppl 3","key":"key\n\t\t\t\t20170522094145_KWU159C6","first-page":"S3\/155","article-title":"Chapter 18: public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling","volume":"24","year":"2006","journal-title":"Vaccine"},{"issue":"7","key":"key\n\t\t\t\t20170522094145_KWU159C7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/11314830-000000000-00000","article-title":"Calibration methods used in cancer simulation models and suggested reporting guidelines","volume":"27","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"488","key":"key\n\t\t\t\t20170522094145_KWU159C8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1198\/jasa.2009.ap07466","article-title":"Bayesian calibration of microsimulation models","volume":"104","year":"2009","journal-title":"J Am Stat Assoc"},{"key":"key\n\t\t\t\t20170522094145_KWU159C9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-9-119","article-title":"Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model","volume":"9","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"2","key":"key\n\t\t\t\t20170522094145_KWU159C10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"20","key":"key\n\t\t\t\t20170522094145_KWU159C11","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522094145_KWU159C12","volume-title":"Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force","year":"2011"},{"issue":"2","key":"key\n\t\t\t\t20170522094145_KWU159C13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multiparameter calibration of a natural history model of cervical cancer","volume":"166","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"key\n\t\t\t\t20170522094145_KWU159C14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report","volume":"127","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"key\n\t\t\t\t20170522094145_KWU159C15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"key\n\t\t\t\t20170522094145_KWU159C16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key\n\t\t\t\t20170522094145_KWU159C17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"key\n\t\t\t\t20170522094145_KWU159C18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522094145_KWU159C19","doi-asserted-by":"crossref","first-page":"b3884","DOI":"10.1136\/bmj.b3884","article-title":"Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States","volume":"339","year":"2009","journal-title":"BMJ"},{"issue":"33","key":"key\n\t\t\t\t20170522094145_KWU159C20","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16, 18 vaccination in Brazil","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170522094145_KWU159C21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-5-11","article-title":"Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination","volume":"5","year":"2007","journal-title":"Popul Health Metr"},{"issue":"37","key":"key\n\t\t\t\t20170522094145_KWU159C22","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica","volume":"26","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"key\n\t\t\t\t20170522094145_KWU159C23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/425907","article-title":"Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results","volume":"190","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"key\n\t\t\t\t20170522094145_KWU159C24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"key\n\t\t\t\t20170522094145_KWU159C25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"6","key":"key\n\t\t\t\t20170522094145_KWU159C26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","year":"1999","journal-title":"Stat Med"},{"issue":"10","key":"key\n\t\t\t\t20170522094145_KWU159C27","first-page":"1029","article-title":"A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia","volume":"10","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"key\n\t\t\t\t20170522094145_KWU159C28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","year":"2008","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170522094145_KWU159C29","volume-title":"Cancer Incidence in Five Continents. Vols. I\u2013VIII.","year":"2005"},{"key":"key\n\t\t\t\t20170522094145_KWU159C30","volume-title":"SEER Cancer Statistics Review, 1975\u20132001","year":"2004"},{"issue":"12","key":"key\n\t\t\t\t20170522094145_KWU159C31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","year":"2000","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522094145_KWU159C32","volume-title":"Evaluation of Cervical Cytology","year":"1999"},{"key":"key\n\t\t\t\t20170522094145_KWU159C33","volume-title":"SEER*Stat Database: Incidence\u2014SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases Nov 2011 Sub (1973\u20132009 Varying)\u2014Linked to County Attributes\u2014Total U.S., 1969\u20132010 Counties","author":"Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, Division of Cancer Control and Population Sciences.","year":"2012"},{"issue":"1","key":"key\n\t\t\t\t20170522094145_KWU159C34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"132","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170522094145_KWU159C35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","article-title":"Prevalence and determinants of HPV infection among Colombian women with normal cytology","volume":"87","year":"2002","journal-title":"Br J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170522094145_KWU159C36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1470-2045(09)70385-7","article-title":"Benefits and risks of HPV testing in cervical cancer screening","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"issue":"22","key":"key\n\t\t\t\t20170522094145_KWU159C37","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jnci\/djs395","article-title":"Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis","volume":"104","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"key\n\t\t\t\t20170522094145_KWU159C38","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","year":"2006","journal-title":"PLoS Med"},{"issue":"3","key":"key\n\t\t\t\t20170522094145_KWU159C39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.bjc.6603575","article-title":"Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland","volume":"96","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"key\n\t\t\t\t20170522094145_KWU159C40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"key\n\t\t\t\t20170522094145_KWU159C41","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t20170522094145_KWU159C42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","year":"2002","journal-title":"Epidemiology"},{"issue":"8","key":"key\n\t\t\t\t20170522094145_KWU159C43","doi-asserted-by":"crossref","first-page":"e72088","DOI":"10.1371\/journal.pone.0072088","article-title":"Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"key\n\t\t\t\t20170522094145_KWU159C44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/jir342","article-title":"Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States\u2014National Health and Nutrition Examination Survey, 2003\u20132006: opportunity to measure HPV vaccine impact?","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"key\n\t\t\t\t20170522094145_KWU159C45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/infdis\/jir341","article-title":"Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003\u20132006","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t20170522094145_KWU159C46","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1002\/ijc.27532","article-title":"Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16","volume":"131","year":"2012","journal-title":"Int J Cancer"},{"issue":"18","key":"key\n\t\t\t\t20170522094145_KWU159C47","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","article-title":"Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance","volume":"287","year":"2002","journal-title":"JAMA"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/180\/5\/545\/17342218\/kwu159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T01:46:40Z","timestamp":1503625600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwu159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,7,31]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwu159","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}